Sandbox:Ifeoma Anaya: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
!style="background:#4479BA; color: #FFFFFF;" align="center" + |
!style="background:#4479BA; color: #FFFFFF;" align="center" + |
|-
|-
|SCC
| align="center" style="background:#DCDCDC;" + |SCC
|
|
|
|
|
|
|-
|-
|BCC
| align="center" style="background:#DCDCDC;" + |BCC
|
|
|
|
|
|
|-
|-
|Melanoma
| align="center" style="background:#DCDCDC;" + |Melanoma
|
|
|
|

Revision as of 18:32, 28 August 2020

classification
SCC
BCC
Melanoma

Practice here

[1]


Mitosis in neuroendocrine tumor. Source: Wikimedia commons
Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -







References

  1. Kiran U, Aggarwal S, Choudhary A, Uma B, Kapoor PM (2017). "The blalock and taussig shunt revisited". Ann Card Anaesth. 20 (3): 323–330. doi:10.4103/aca.ACA_80_17. PMC 5535574. PMID 28701598.